Author

M. S. A. Gilman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:protein folding & dynamics· 2 Organism:bacteria (other)· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Kruse· 2 shared C. McMahon· 2 shared L. M. Wingler· 2 shared A. G. Schmidt· 1 shared A. Wellner· 1 shared B. M. Hauser· 1 shared C. C. Liu· 1 shared C. D. Bahl· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. C. Kruse

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivAug 23, 2023

Antibodies Expand the Scope of Angiotensin Receptor Pharmacology

M. A. Skiba, S. M. Sterling, S. Rawson…·A. C. Kruse

This study develops nanobody antagonists against the AT1R receptor, showing they can selectively bind and modulate the receptor with tunable ligand selectivity.

DOI 10.1038/s41589-024-01620-6

humanexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivJan 20, 2021

Biochemical and Structural Characterization of Two Cif-Like Epoxide Hydrolases from Burkholderia cenocepacia

N. M. Taher, K. L. Hvorecny, C. M. Burke…·D. R. Madden

This study characterizes two Cif-like epoxide hydrolases from Burkholderia cenocepacia, revealing their biochemical properties and structural differences.

DOI 10.1016/j.crstbi.2021.02.002

bacteria (other)protein structure

𝕏 PostBluesky

BioengineeringbioRxivNov 11, 2020

Rapid generation of potent antibodies by autonomous hypermutation in yeast

A. Wellner, C. McMahon, M. S. A. Gilman…·C. C. Liu

This paper introduces AHEAD, a yeast-based system for rapid antibody generation through autonomous hypermutation, achieving high-affinity antibodies against SARS-CoV-2 and other targets in just 2 weeks.

DOI 10.1038/s41589-021-00832-4

yeastproteomics

𝕏 PostBluesky